ResMed has launched a rebrand to unify its portfolio and reflect its increasing direct-to-consumer engagement.

Resmed (NYSE: RMD) announced today that it began a comprehensive brand evolution to unify its brand portfolio.

ResMed's second-quarter revenue rose 10% to $1.28 billion, driven by increased demand for its sleep devices and the masks portfolio. Analysts on average had expected quarterly revenue of $1.27 ...

ResMed's significant 11% year-over-year revenue growth was primarily propelled by innovations and strong demand for its sleep devices and masks. The gross margin boost was aided by manufacturing ...